J05AR10 · Anti-infectives for systemic use
Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan)
Indications
Lopinavir/ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (HIV-1) infected adults, adolescents and children above the age of 2 years. The choice of lopinavir/ritonavir to treat protease inhibitor experienced HIV-1 infected patients should be based on individual viral resistance testing and treatment history of patients.
Composition
- Active substance
- lopinavir, ritonavir
- International name (INN)
- lopinavir;ritonavir
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan)
- Active substance
- lopinavir, ritonavir
- ATC code
- J05AR10